Premium
Peptide Specificity of Anti‐Myelin Basic Protein Antibodies in Patients with Acute Optic Neuritis and the HLA System
Author(s) -
SELLEBJERG F.,
FREDERIKSEN J. L.,
OLSSON T.,
LINK H.,
MADSEN H. O.,
RYDER L. P.,
SVEJGAARD A.
Publication year - 1994
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1994.tb03415.x
Subject(s) - optic neuritis , multiple sclerosis , myelin basic protein , antibody , medicine , immunology , human leukocyte antigen , cerebrospinal fluid , central nervous system , myelin , antigen , peptide , biology , biochemistry
Multiple sclerosis (MS) may be an autoimmune disease, partially caused by autoreactivity to myelin basic protein (MBP) and other central nervous system proteins. Acute optic neuritis (ON) is a frequent first symptom of MS. The role of the HLA system in anti‐MBP antibody production in ON was investigated employing a restriction fragment length polymorphism system for genomic HLA‐DQ and ‐DR typing and an immunospot assay for the detection of individual cells secreting antibodies to three different synthetic MBP peptides. Thirty‐two out of 40 patients (80%) with ON had cells in cerebrospinal fluid secreting anti‐MBP peptide antibodies while this occurred in 10/19 patients with other neurological diseases (53%; mainly in patients with inflammatory diseases in the central nervous system). This difference was statistically significant ( P = 0.03). None of the three examined peptides were immunodominant in any patient group. It was found, however, that presence of HLA DR15, which is associated with MS, may be associated further with predominant production of antibodies to the MBP amino acids 63–88 in patients with ON ( P = 0.002, corrected for multiple comparisons).